01 24AstraZeneca Canada Inc.
01 62388818
02 22402894
03 62486539
04 22568391
05 42653344
06 22681526
07 22780941
01 8DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
02 8DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE | METFORMIN HYDROCHLORIDE
03 8SAXAGLIPTIN HYDROCHLORIDE | DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
01 24TABLET
01 62020-10-02
02 22021-03-05
03 62023-05-15
04 22025-05-26
05 42027-06-21
06 22028-03-21
07 22030-11-12
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2486539
Filing Date : 2003-05-15
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2388818
Filing Date : 2000-10-02
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2486539
Filing Date : 2003-05-15
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2388818
Filing Date : 2000-10-02
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
Patent Expiration Date : 2028-03-21
Date Granted : 2016-07-19
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2681526
Filing Date : 2008-03-21
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-21
Date Granted : 2016-07-19
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2653344
Filing Date : 2007-06-21
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
Patent Expiration Date : 2028-03-21
Date Granted : 2016-07-19
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2681526
Filing Date : 2008-03-21
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-21
Date Granted : 2016-07-19
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Brand Name : FORXIGA
Patent Number : 2653344
Filing Date : 2007-06-21
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2653344
Filing Date : 2007-06-21
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2388818
Filing Date : 2000-10-02
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
